T. Rowe Price Investment Management
ASND icon

T. Rowe Price Investment Management’s Ascendis Pharma A/S ASND Stock Holding History

T. Rowe Price Investment Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8B Buy
6,754,846
+592,804
+10% +$138M 1.18% 13
2026
Q1 		$1.41B Buy
6,162,042
+4,494,417
+270% +$1.01B 0.97% 19
2025
Q4 		$356M Sell
1,667,625
-998,993
-37% -$206M 0.22% 111
2025
Q3 		$530M Sell
2,666,618
-916,928
-26% -$171M 0.32% 85
2025
Q2 		$619M Buy
3,583,546
+529,722
+17% +$86.3M 0.39% 72
2025
Q1 		$476M Buy
3,053,824
+328,278
+12% +$46.9M 0.31% 93
2024
Q4 		$375M Buy
2,725,546
+960,504
+54% +$126M 0.23% 116
2024
Q3 		$264M Buy
1,765,042
+1,734,478
+5,675% +$234M 0.16% 152
2024
Q2 		$4.17M Sell
30,564
-2,538,339
-99% -$345M ﹤0.01% 575
2024
Q1 		$388M Sell
2,568,903
-1,420,927
-36% -$203M 0.24% 111
2023
Q4 		$503M Buy
3,989,830
+5,327
+0.1% +$531K 0.33% 92
2023
Q3 		$373M Buy
3,984,503
+1,610
+0% +$151K 0.26% 108
2023
Q2 		$355M Buy
3,982,893
+509,427
+15% +$44.3M 0.24% 117
2023
Q1 		$372M Buy
3,473,466
+645,199
+23% +$73.8M 0.27% 104
2022
Q4 		$345M Buy
2,828,267
+796,087
+39% +$92.4M 0.27% 103
2022
Q3 		$210M Buy
+2,032,180
New +$193M 0.17% 140

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Investment Management's ASND Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Ascendis Pharma A/S (ASND) stake by 9.6% in Q2 2026, buying an estimated $138M and bringing the position to 6,754,846 shares worth $1.8B. The position accounts for 1.18% of the portfolio, ranked #13.

T. Rowe Price Investment Management first reported a position in ASND in Q3 2022 and has held it in 16 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • T. Rowe Price Investment Management held 6,754,846 shares of Ascendis Pharma A/S worth $1.8B as of Q2 2026.
  • T. Rowe Price Investment Management bought 592,804 Ascendis Pharma A/S shares in Q2 2026, an estimated $138M.
  • Ascendis Pharma A/S made up 1.18% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #13 holding.
  • T. Rowe Price Investment Management first reported a position in Ascendis Pharma A/S in Q3 2022 and has held it in 16 quarters since.
  • 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.